These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17371231)

  • 61. Phosphoinositide 3-kinases in immunity: lessons from knockout mice.
    Sasaki T; Suzuki A; Sasaki J; Penninger JM
    J Biochem; 2002 Apr; 131(4):495-501. PubMed ID: 11926985
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms.
    Fyffe C; Buus R; Falasca M
    Curr Pharm Des; 2013; 19(4):680-6. PubMed ID: 23016860
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PI3K inhibitors in inflammation, autoimmunity and cancer.
    Stark AK; Sriskantharajah S; Hessel EM; Okkenhaug K
    Curr Opin Pharmacol; 2015 Aug; 23():82-91. PubMed ID: 26093105
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Signaling by the phosphoinositide 3-kinase family in immune cells.
    Okkenhaug K
    Annu Rev Immunol; 2013; 31():675-704. PubMed ID: 23330955
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phosphatidylinositol 3-kinase signaling and immune regulation: insights into disease pathogenesis and clinical implications.
    Nguyen T; Deenick EK; Tangye SG
    Expert Rev Clin Immunol; 2021 Aug; 17(8):905-914. PubMed ID: 34157234
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PI3K comes of age.
    Ward SG; Finan P; Welham MJ
    Nat Immunol; 2003 Jan; 4(1):2. PubMed ID: 12496966
    [No Abstract]   [Full Text] [Related]  

  • 67. A Case for Phosphoinositide 3-Kinase-Targeted Therapy for Infectious Disease.
    Adefemi F; Fruman DA; Marshall AJ
    J Immunol; 2020 Dec; 205(12):3237-3245. PubMed ID: 33288538
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Knockout mice: a paradigm shift in modern immunology.
    Mak TW; Penninger JM; Ohashi PS
    Nat Rev Immunol; 2001 Oct; 1(1):11-9. PubMed ID: 11905810
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Unique and redundant roles of class IA PI3Kinase regulatory subunits in mast cell development.
    Mali RS; Kapur R
    Cell Cycle; 2013 Jan; 12(1):7-8. PubMed ID: 23255115
    [No Abstract]   [Full Text] [Related]  

  • 70. Signal 3 and its role in autoimmunity.
    Thomas R
    Arthritis Res Ther; 2004; 6(1):26-27. PubMed ID: 14979929
    [No Abstract]   [Full Text] [Related]  

  • 71. PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt.
    Uche UU; Piccirillo AR; Kataoka S; Grebinoski SJ; D'Cruz LM; Kane LP
    J Exp Med; 2018 Dec; 215(12):3165-3179. PubMed ID: 30429249
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of diacylglycerol kinases in T cell development and function.
    Krishna S; Zhong X
    Crit Rev Immunol; 2013; 33(2):97-118. PubMed ID: 23582058
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β.
    Cai X; Srivastava S; Sun Y; Li Z; Wu H; Zuvela-Jelaska L; Li J; Salamon RS; Backer JM; Skolnik EY
    Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20072-7. PubMed ID: 22128329
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk.
    Wang H; Jin Y; Reddy MV; Podolsky R; Liu S; Yang P; Bode B; Reed JC; Steed RD; Anderson SW; Steed L; Hopkins D; Huang Y; She JX
    PLoS One; 2010 Jul; 5(7):e11789. PubMed ID: 20668683
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The regulation of class IA PI 3-kinases by inter-subunit interactions.
    Backer JM
    Curr Top Microbiol Immunol; 2010; 346():87-114. PubMed ID: 20544340
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The class II phosphatidylinositol 3 kinase C2beta is required for the activation of the K+ channel KCa3.1 and CD4 T-cells.
    Srivastava S; Di L; Zhdanova O; Li Z; Vardhana S; Wan Q; Yan Y; Varma R; Backer J; Wulff H; Dustin ML; Skolnik EY
    Mol Biol Cell; 2009 Sep; 20(17):3783-91. PubMed ID: 19587117
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Critical roles of the PI3K/Akt signaling pathway in T cell development.
    Juntilla MM; Koretzky GA
    Immunol Lett; 2008 Mar; 116(2):104-10. PubMed ID: 18243340
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lymphocyte cell motility: the twisting, turning tale of phosphoinositide 3-kinase.
    Oak JS; Matheu MP; Parker I; Cahalan MD; Fruman DA
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1109-13. PubMed ID: 17956290
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity.
    Fruman DA
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):177-80. PubMed ID: 17371231
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of phosphoinositide 3-kinase signaling in autoimmunity.
    Oak JS; Fruman DA
    Autoimmunity; 2007 Sep; 40(6):433-41. PubMed ID: 17729037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.